Industry Outlook and Trend Analysis
The Peptide Therapeutics Market was worth USD 19.52 billion in 2014 and is expected to reach approximately USD 42.97 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 9.16% during the forecast period. Expanding prevalence of cancer and metabolic disorders, for example, obesity, diabetes, and osteoporosis are the key variables contributing toward the adoption of peptide therapeutics over the conjecture time frame. The demand for low-cost and efficient drugs is high because of developing base of affected paediatric populace and predominance of target diseases in countries with a low income. The development is specifically connected with rising interests in drug revelation.
Application Outlook and Trend Analysis
The cancer section ruled in 2016 with revenue share of over USD 1.85 billion. Expanding prevalence of cancer worldwide and expanding prescription of peptide therapeutics for malignancy treatment are the key components in charge of predominance in this fragment. Rising demand for rapid-acting and efficient therapeutics is foreseen to highlight development.
Type Outlook and Trend Analysis
The innovative peptides ruled in 2016 and held a share of around 66.93%, inferable from the expanding ventures by vast pharmaceuticals in R&D for the improvement of novel drugs and high prescription rate. Nonetheless, generics are expected to encounter lucrative growth over the conjecture time frame.
Manufacturing type Outlook and Trend Analysis
The in-house manufacturing section held the biggest share representing more than 60.0% in 2016. Majority of the key players are engaged with developing peptide therapeutics in-house attributable to stringent regulations and increasing expenses of outsourcing. As huge pharmaceutical organizations have legitimate infrastructure for large-scale manufacturing and advanced technology, these organizations favour in-house manufacturing.
Route of administration Outlook and Trend Analysis
The biopharmaceuticals giants are constantly examining new techniques for drug delivery suitable to peptides. Novel drug delivery technologies are presently being evaluated for efficacy with engineered molecules containing advanced PEGylation, trying to enhance performance of drug delivery performance through better methods of drug delivery. Parenteral course of administration commanded in 2016 with a significant share of the market.
Synthesis Technology Outlook and Trend Analysis
The LPPS section ruled with share of more than 45.0% in 2016 attributable to existence of growing demand for unadulterated peptides for improvement of effective therapeutics. Nonetheless, issues, for example, higher usage of time are in charge of switching preferences of consumers to effective and faster methods, for example, SPPS.
Regional Outlook and Trend Analysis
North America commanded the market in 2016. Increasing awareness levels relating to peptide therapeutics products, expanding interest for diagnostics in cancer and other diseases, and developing biotechnology sector are the components contributing toward the strength. Expanding R&D expenditure by government is additionally assessed to enable peptide therapeutics to keep up predominance over the coming years.
The leading players in the market are Sanofi, Lonza Group, GlaxoSmithKline, Pfizer, Eli Lilly and Company, Novo Nordisk, Teva Pharmaceutical Industries, Novartis, Takeda Pharmaceutical Company, Bristol-Myers Squibb, AstraZeneca and Amgen. Improvement of new products and adopting technological progressions are key methods attempted by the organizations to maintain market position. In addition, expanding collaborations for undertaking trials of new drugs is evaluated to increment competition.
The Peptide Therapeutics Market is segmented as follows-
By Type of Manufacturers:
By Route of Administration:
By Synthesis Technology:
Liquid Phase Peptide Synthesis (LPPS)
Solid Phase Peptide Synthesis (SPPS)
Rest of Europe
Rest of Asia-Pacific
Rest of South America
Middle East and Africa
Rest of MEA
Some of the key questions answered by the report are:
What was the market size in 2014 and forecast from 2015 to 2023?
What will be the industry market growth from 2015 to 2023?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?